Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 14 hours agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 2 hours agoNet product sales plummeted by 91% compared to Q1 2023. This downturn...transition to a seasonal market for Covid-19 vaccines. During Q1 2023, Moderna...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 5 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 day agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 14 hours agoThe biotechnology company, known for its mRNA vaccine technology, highlighted its strategic...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 23 hours agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 2 hours agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 2 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 2 days agoSouth African officials said that the decision to give a three-year contract to Indian generic...
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 4 hours agoQ: Can you discuss the enrollment updates for the nivolumab and Brentiximab vaccine trial? A: Karen Sims clarified that the target enrollment was 20 subjects, consistent with ...
